View the report as separate downloadable parts:
Committee Members
Terms of Reference
Abbreviations
List of Recommendations
Chapter 1—Introduction
Purpose of the inquiry
Report structure
Conduct of the inquiry
Medicinal cannabis
The role of the Therapeutic Goods Administration (TGA)
The role of the Office of Drug Control (ODC)
The role of state and territory governments
Chapter 2—Education and information
Education about medicinal cannabis
Training
Information about accessing medicinal cannabis
Committee view
Chapter 3—Access pathways and regulatory hurdles
Introduction
Special Access Scheme
Authorised Prescriber scheme
Clinical trials
Alternatives proposed to the current TGA pathways
Committee view
Committee view
Jurisdiction-specific regulatory requirements
International jurisdictions and their access models
Committee view
Chapter 4—Products and supply
Regulating medicinal cannabis products
Committee view
Medicinal cannabis supply in Australia
Committee view
Chapter 5—Costs and other barriers
The costs of accessing medicinal cannabis
The 'green market' – illicit cannabis for medicinal purposes
Driving laws and medicinal cannabis
Committee view
Appendix 1—Submissions and additional information
Appendix 2—Public hearings